PIONEER UK HOLDINGS LIMITED

Figures converted to GBP from USD at 0.748 per USD (Frankfurter spot rate) — hover any figure for the original. — indicates the figure wasn't present under that line item in that period. About these numbers

• Turnover

  —

  Not reported

• Cash

  —

  Not reported

• Net assets

  0%

  £163,041,041 → £163,041,041

• Employees

  —

  Not reported

Each % is (latest − prior) ÷ |prior| for the line item as filed. The comparison is only shown when the latest and prior accounts cover broadly equal-length periods — short or long stubs (typical around incorporation or a year-end change) are suppressed rather than misrepresented. Lines a company doesn't report are omitted. About these numbers

Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.

Accounting basis

FRS 102

Reporting scope

Standalone (parent only)

Auditor

PricewaterhouseCoopers LLP

Audit opinion

Unqualified (clean)

Going concern

Affirmed

“After making reasonable enquiries and assessing forecasts (up to 31 December 2026) including severe, but plausible and downside scenarios, the directors have a reasonable expectation that the Company has adequate resources to continue in operational existence for the foreseeable future.”

Group structure

1. PIONEER UK HOLDINGS LIMITED · parent
   1. PCI Penn UK Holdco Limited 100% · Holding Company
   2. Biotec Services International Limited 100% · Pharmaceutical Services
   3. AndersonBrecon (UK) Limited 100% · Pharmaceutical Services
   4. Penn Pharma Group Limited 100% · Holding Company
   5. Penn Pharmaceuticals Services Limited 100% · Pharmaceutical Services
   6. Millmount Healthcare Limited 100% · Ireland · Pharmaceutical Services

Significant events

• “On 11 July 2025, the current owners of the Parent Company (KPCI Holdings Ltd.) entered into a recapitalisation agreement with Maverick Intermediate Holdings Limited (buyer), valuing the Group at approximately $9.8bn. Following regulatory approval, the recapitalisation took place on 15 October 2025.”
• “On 13 October 2025, the Company issued 218,100,000 ordinary shares of $1.00 nominal value which were paid up in full by appreciation of the Company's capital contribution reserve balances.”
• “On 15 October 2025, as a part of the recapitalization of the ultimate parent company, the Company borrowed $190,000,000 less fees of $2,956,052, for net borrowings of $187,043,948.”
• “A dividend was then issued for $295,332,550 to the Company's immediate parent Pioneer UK Midco 2 Limited, which was ultimately distributed to the ultimate parent KPCI Holdings Ltd. as a part of the recapitalization transaction.”

Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers

Filings

11

last 12 months

Capital events

3

last 24 months

Officers appointed

1

last 12 months

Officers resigned

1

last 12 months

Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.